Cardiovascular disease (CVD) mortality in the United Kingdom has decreased significantly over the past 30 years, but its prevalence has shown little change, and major differences exist in the burden of CVD among the four constituent countries and between men and women, a review has found.
Researchers from the United Kingdom have identified genetic differences that affect the likelihood of whether a person will smoke and the predisposition of heavy smokers and non-smokers to poor lung health
People whose jobs are predominantly desk based should be encouraged to stand up and walk about for at least two hours during each working day, says the first UK guidance developed to reduce the health risks of prolonged sitting at work.
Growing evidence has shown links between a sedentary lifestyle and an increased risk of cardiovascular disease, diabetes, and some cancers. To help reduce this risk Public Health England and a UK community interest company, Active Working, asked an international group of experts in the field to review the available evidence and develop guidelines for employers to promote avoidance of prolonged periods of sedentary work
This week’s news:
Lifecourse tracker: wave 1 spring 2012: interim summary report
This report is a summary of the first stage of research that records how health behaviours vary across life stages. It forms a baseline against which changes in behaviour over time and seasonal variations can be assessed and also informs the Department of Health’s social marketing strategy.
Living well for longer: a call to action to reduce avoidable premature mortality
This discussion paper aims to challenge and inspire the health and social care system to take action to reduce the numbers of people dying prematurely.
Cardiovascular disease outcomes strategy: improving outcomes for people with or at risk of cardiovascular disease
This strategy document provides advice to local authority and NHS commissioners and providers about actions to improve cardiovascular disease outcomes. It sets out outcomes for people with or at risk of cardiovascular disease in line with the NHS and public health outcomes frameworks.
A blood test could help predict breast cancer survival. More – click here >>
This week read our clinical article on meningitis, a serious condition where prompt diagnosis and treatment improve both morbidity and mortality. To read more on this article click here >>
The European Medicines Agency has granted marketing authorisation for Signifor, an orphan medicine, used for treating Cushing’s disease when surgery has failed. To read more on this article click here >>
At least seven models are commonly used to evaluate cardiovascular risk. A systematic review of comparative studies in the BMJ investigates which has the best prognostic performance. To read more on this article click here >>
Full text extract from NHS Evidence: Sept 2011
Overview: Aspirin is one of the most used medicines. It has long been a major analgesic and antipyretic, and now is widely used in lower doses as an antiplatelet agent helping to reduce heart disease and strokes.
Research has shown aspirin to be effective in decreasing cardiovascular morbidity and mortality in patients with clinical evidence of cardiovascular disease (BMJ Clin Res ed. 2002 Jan 12;324(7329):71-86 and Berger JS et al, Am J Med. 2008 Jan;121(1):43-9). However, there is ongoing debate about the role of aspirin in the prevention of cardiovascular disease for people without the condition.